Land: Israel
Språk: engelsk
Kilde: Ministry of Health
PERAMPANEL AS ANHYDROUS
EISAI ISRAEL LTD., ISRAEL
N03AX22
SUSPENSION
PERAMPANEL AS ANHYDROUS 0.5 MG / 1 ML
PER OS
Required
EISAI MANUFACTURING LIMITED, UK
PERAMPANEL
Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalized tonic-clonic seizures in patients with epilepsy aged 12 years and older with idiopathic generalised epilepsy.
2023-05-16
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS - 1986 This medicine is to be supplied upon physician’s prescription only FYCOMPA ORAL SUSPENSION, 0.5 MG/ML COMPOSITION: ACTIVE INGREDIENT: Perampanel (as anhydrous) 0.5 mg/ml For the full list of ingredients and a list of allergens, see: Section 6, "Additional information". READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, consult your physician or pharmacist. This medicine has been prescribed to treat your illness. Do not pass it on to others. It may harm them even if it seems to you that their illness is similar. 1. WHAT IS THIS MEDICINE INTENDED FOR? FYCOMPA in combination with other antiepileptic drugs is intended to treat the following: - Epilepsy characterized by partial-onset seizures with or without secondarily generalized seizures in adults and in children over 4 years old. - Generalized idiopathic epilepsy characterized by seizures that affect the entire brain (primary generalized tonic-clonic seizures) in adults and children over 12 years old. THERAPEUTIC GROUP: Selective non-competitive AMPA receptor antagonist. FYCOMPA belongs to a group of anti-epileptic medicines. These medicines are used to treat epilepsy - a disease characterized by seizures that occur repeatedly. FYCOMPA has been given to you as treatment to reduce the frequency of the seizures that you suffer from. 2. BEFORE USING THE MEDICINE: DO NOT USE THIS PREPARATION IF: • You have ever had a severe skin rash or skin peeling, blistering and/or mouth sores after taking Perampanel. • You are sensitive (allergic) to the active ingredient Perampanel or to any of the additional ingredients that the medicine contains (please see Section 6 - "Additional information"). SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE: BEFORE TREATMENT WITH FYCOMPA, TELL YOUR PHYSICIAN IF: • You suffer from liver problems. • You suffer from moderate or severe kidney p Les hele dokumentet
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Fycompa Oral suspension Fycompa 2 mg film-coated tablets Fycompa 4 mg film-coated tablets Fycompa 6 mg film-coated tablets Fycompa 8 mg film-coated tablets Fycompa 10 mg film-coated tablets Fycompa 12 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Fycompa Oral suspension Each ml of oral suspension contains 0.5 mg perampanel Each bottle of 340 ml contains 170 mg perampanel Excipient with known effect: Each ml of oral suspension contains 175 mg sorbitol (E420). For the full list of excipients, see section 6.1. Fycompa 2 mg film-coated tablets Each film-coated tablet contains 2 mg perampanel. Excipient with known effect: Each 2 mg tablet contains 78.5 mg of lactose (as monohydrate). For the full list of excipients, see section 6.1. Fycompa 4 mg film-coated tablets Each film-coated tablet contains 4 mg perampanel. Excipient with known effect: Each 4 mg tablet contains 157.0 mg of lactose (as monohydrate). For the full list of excipients, see section 6.1. Fycompa 6 mg film-coated tablets Each film-coated tablet contains 6 mg perampanel. Excipient with known effect: Each 6 mg tablet contains 151.0 mg of lactose (as monohydrate). For the full list of excipients, see section 6.1. Fycompa 8 mg film-coated tablets Each film-coated tablet contains 8 mg perampanel. Excipient with known effect: Each 8 mg tablet contains 149.0 mg of lactose (as monohydrate). 2 For the full list of excipients, see section 6.1. Fycompa 10 mg film-coated tablets Each film-coated tablet contains 10 mg perampanel. Excipient with known effect: Each 10 mg tablet contains 147.0 mg of lactose (as monohydrate). For the full list of excipients, see section 6.1. Fycompa 12 mg film-coated tablets Each film-coated tablet contains 12 mg perampanel. Excipient with known effect: Each 12 mg tablet contains 145.0 mg of lactose (as monohydrate). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension White to off-white suspension FILM-COATED Les hele dokumentet